Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma

Completed · Not applicable

Conditions studied: Lymphoblastic Lymphoma

In brief

The main purpose of this study is to determine if it is feasible to administer an intensified, multi-agent chemotherapy regimen for children with stage III and IV non-Hodgkin lymphoma and to find out what the toxicities are.

Key facts

Study ID

NCT00187122

Run by

St. Jude Children's Research Hospital

People needed

42

Starts

1993-03-01

Expected to finish

2004-06-01

Last updated by the study team

2008-04-23

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Stage III or IV Lymphoblastic Lymphoma
• One week or less of prior therapy, only to include steroids, vinca alkaloids, and emergency radiation therapy to the mediastinum in those with severe respiratory.

You may not qualify if…

• Patients with superior vena cava syndrome, significant compression of the trachea requiring more than 40% oxygen or having significant dyspnea at normal activity

Where it is running

• St. Jude Children's Research Hospital — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.